136 related articles for article (PubMed ID: 17723170)
1. Oriental herbs as a source of novel anti-androgen and prostate cancer chemopreventive agents.
Lu J; Kim SH; Jiang C; Lee H; Guo J
Acta Pharmacol Sin; 2007 Sep; 28(9):1365-72. PubMed ID: 17723170
[TBL] [Abstract][Full Text] [Related]
2. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.
Jiang C; Lee HJ; Li GX; Guo J; Malewicz B; Zhao Y; Lee EO; Lee HJ; Lee JH; Kim MS; Kim SH; Lu J
Cancer Res; 2006 Jan; 66(1):453-63. PubMed ID: 16397261
[TBL] [Abstract][Full Text] [Related]
3. A novel class of pyranocoumarin anti-androgen receptor signaling compounds.
Guo J; Jiang C; Wang Z; Lee HJ; Hu H; Malewicz B; Lee HJ; Lee JH; Baek NI; Jeong JH; Kim DK; Kang KS; Kim SH; Lu J
Mol Cancer Ther; 2007 Mar; 6(3):907-17. PubMed ID: 17363485
[TBL] [Abstract][Full Text] [Related]
4. A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo.
Zhang Y; Shaik AA; Xing C; Chai Y; Li L; Zhang J; Zhang W; Kim SH; Lü J; Jiang C
Invest New Drugs; 2012 Oct; 30(5):1820-9. PubMed ID: 21870073
[TBL] [Abstract][Full Text] [Related]
5. Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models.
Wu W; Tang SN; Zhang Y; Puppala M; Cooper TK; Xing C; Jiang C; Lü J
Am J Chin Med; 2017; 45(8):1773-1792. PubMed ID: 29121805
[TBL] [Abstract][Full Text] [Related]
6. Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells.
Lin FM; Chen LR; Lin EH; Ke FC; Chen HY; Tsai MJ; Hsiao PW
Carcinogenesis; 2007 Dec; 28(12):2521-9. PubMed ID: 17942463
[TBL] [Abstract][Full Text] [Related]
7. Natural Korean Medicine Dang-Gui: Biosynthesis, Effective Extraction and Formulations of Major Active Pyranocoumarins, Their Molecular Action Mechanism in Cancer, and Other Biological Activities.
Reddy CS; Kim SC; Hur M; Kim YB; Park CG; Lee WM; Jang JK; Koo SC
Molecules; 2017 Dec; 22(12):. PubMed ID: 29215592
[No Abstract] [Full Text] [Related]
8. A novel dietary flavonoid fisetin inhibits androgen receptor signaling and tumor growth in athymic nude mice.
Khan N; Asim M; Afaq F; Abu Zaid M; Mukhtar H
Cancer Res; 2008 Oct; 68(20):8555-63. PubMed ID: 18922931
[TBL] [Abstract][Full Text] [Related]
9. Herbal extract of Wedelia chinensis attenuates androgen receptor activity and orthotopic growth of prostate cancer in nude mice.
Tsai CH; Lin FM; Yang YC; Lee MT; Cha TL; Wu GJ; Hsieh SC; Hsiao PW
Clin Cancer Res; 2009 Sep; 15(17):5435-44. PubMed ID: 19690196
[TBL] [Abstract][Full Text] [Related]
10. Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.
Jiang C; Guo J; Wang Z; Xiao B; Lee HJ; Lee EO; Kim SH; Lu J
Breast Cancer Res; 2007; 9(6):R77. PubMed ID: 17986353
[TBL] [Abstract][Full Text] [Related]
11. In vivo anti-cancer activity of Korean Angelica gigas and its major pyranocoumarin decursin.
Lee HJ; Lee HJ; Lee EO; Lee JH; Lee KS; Kim KH; Kim SH; Lü J
Am J Chin Med; 2009; 37(1):127-42. PubMed ID: 19222117
[TBL] [Abstract][Full Text] [Related]
12. Decursin suppresses human androgen-independent PC3 prostate cancer cell proliferation by promoting the degradation of beta-catenin.
Song GY; Lee JH; Cho M; Park BS; Kim DE; Oh S
Mol Pharmacol; 2007 Dec; 72(6):1599-606. PubMed ID: 17855653
[TBL] [Abstract][Full Text] [Related]
13. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
[TBL] [Abstract][Full Text] [Related]
14. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells.
Gravina GL; Festuccia C; Millimaggi D; Dolo V; Tombolini V; de Vito M; Vicentini C; Bologna M
Prostate; 2008 May; 68(7):793-801. PubMed ID: 18324645
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of androgen receptor by 3,3'-diindolylmethane contributes to inhibition of cell proliferation and induction of apoptosis in both hormone-sensitive LNCaP and insensitive C4-2B prostate cancer cells.
Bhuiyan MM; Li Y; Banerjee S; Ahmed F; Wang Z; Ali S; Sarkar FH
Cancer Res; 2006 Oct; 66(20):10064-72. PubMed ID: 17047070
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous Determination of Decursin, Decursinol Angelate, Nodakenin, and Decursinol of
Kim SJ; Ko SM; Choi EJ; Ham SH; Kwon YD; Lee YB; Cho HY
Molecules; 2018 Apr; 23(5):. PubMed ID: 29701699
[TBL] [Abstract][Full Text] [Related]
17. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
Sadar MD; Gleave ME
Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779
[TBL] [Abstract][Full Text] [Related]
18. Iminoenamine based novel androgen receptor antagonist exhibited anti-prostate cancer activity in androgen independent prostate cancer cells through inhibition of AKT pathway.
Divakar S; Saravanan K; Karthikeyan P; Elancheran R; Kabilan S; Balasubramanian KK; Devi R; Kotoky J; Ramanathan M
Chem Biol Interact; 2017 Sep; 275():22-34. PubMed ID: 28757136
[TBL] [Abstract][Full Text] [Related]
19. Angelica gigas Nakai and Decursin Downregulate Myc Expression to Promote Cell Death in B-cell Lymphoma.
Kim E; Nam J; Chang W; Zulfugarov IS; Okhlopkova ZM; Olennikov D; Chirikova NK; Kim SW
Sci Rep; 2018 Jul; 8(1):10590. PubMed ID: 30002430
[TBL] [Abstract][Full Text] [Related]
20. NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth.
Papaioannou M; Schleich S; Roell D; Schubert U; Tanner T; Claessens F; Matusch R; Baniahmad A
Invest New Drugs; 2010 Dec; 28(6):729-43. PubMed ID: 19771394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
